First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'
CAR-T immunotherapy now available on the NHS for adults with B-cell acute lymphoblastic leukaemia offers rapid, more effective, and potentially curative treatment.
Kennedy Family Scion Pens Heartbreaking Piece On Her Terminal Cancer And RFK Jr's Danger to Health Care
Tatiana Schlossberg has acute myeloid leukemia, faces a terminal prognosis, and attributes research-funding cuts by Robert F. Kennedy Jr. to diminished cancer treatment prospects.
Groundbreaking Cancer Therapy Used for Autoimmune Treatment
CAR‑T cell therapy, proven in B‑cell cancers and multiple myeloma, shows promising long-term remission in autoimmune diseases like lupus, myositis, and scleroderma despite high costs.
A living drug that fits on a spoon saves the lives of eight young people with the most common childhood cancer
A hospital-produced CAR-T living drug saved eight terminal young patients with aggressive B-cell acute lymphoblastic leukemia, showing 70% survival after over eighteen months.
Antonio Perez: We are working on the next generation of off-the-shelf CAR-T cells'
Collaboration between Antonio Perez and Persis Amrolia focuses on advancing research in childhood blood cancers through innovative immunotherapy techniques.
Carl H. June, creator of CAR-T therapies: The genetic medicine of the future will be able to treat everything, from diabetes to chronic infections'
Carl H. June envisions a future in medicine led by personalized gene therapies that can cure numerous diseases, including cancers and chronic conditions.